SCHEMBL6734816

SCHEMBL6734816

CCCCCc1ccc2cc3cc(CCCCC)c(F)c(F)c3cc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 6/20 0.43
BDKRB2 P30411 1/20 0.37
GPR3 P46089 1/20 0.36
HTR1A P08908 1/20 0.36
HTR1D P28221 1/20 0.36
HTR1B P28222 1/20 0.36
S1PR1 P21453 1/20 0.35
S1PR3 Q99500 1/20 0.35
ESR1 P03372 2/20 0.35
ADRA2A P08913 2/20 0.35
ADORA3 P0DMS8 2/20 0.35
TACR2 P21452 2/20 0.35
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
SHBG P04278 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6732184 0.99 TLR8 (0.42) TLR8BDKRB2GPR3HTR1AHTR1D
SCHEMBL6731773 0.99 TLR8 (0.42) TLR8BDKRB2GPR3HTR1AHTR1D
SCHEMBL6735447 0.96 TLR8 (0.40) TLR8BDKRB2GPR3HTR1AHTR1D
SCHEMBL6731904 0.96 TLR8 (0.40) TLR8BDKRB2HTR1AHTR1DHTR1B
SCHEMBL6736893 0.96 TLR8 (0.39) TLR8BDKRB2HTR1A
SCHEMBL6732169 0.93 CYP1A2 (0.39) TLR8BDKRB2TP53CYP3A4
SCHEMBL6731242 0.93 TLR8 (0.40) TLR8BDKRB2HTR1AHTR1DHTR1B
SCHEMBL6741609 0.92 SKP2 (0.36) TLR8BDKRB2HTR1A
SCHEMBL6731332 0.92 TLR8 (0.35) TLR8BDKRB2HTR1A
SCHEMBL6736312 0.89 CYP1A2 (0.40) TLR8BDKRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6682785-B2 A FLUOROANTHRACENE COMPOUNDS; HEAT RESISTANCE, RADIATION RESISTANCE, PHOTOSTABILITY CLARIANT FINANCE (BVI) LIMITED (VG) 2004-01-27 US disclosed
US-20030118749-A1 A fluoroanthracene compounds; heat resistance, radiation resistance, photostability CLARIANT INTERNATIONAL LTD. 2003-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030118749-A1 A fluoroanthracene compounds; heat resistance, radiation resistance, photostability HSF1, ABCC1, FLNA TLR8 3408/4885BDKRB2 3182/4885GPR3 3427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.